KeyBank National Association
ALXN

KeyBank National Association’s Alexion Pharmaceuticals ALXN Stock Holding History

KeyBank National Association’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-1,252
Closed -$230K – 1092
2021
Q2 		$230K Buy
+1,252
New +$215K ﹤0.01% 1009
2018
Q1 		– Sell
-2,046
Closed -$245K – 1099
2017
Q4 		$245K Sell
2,046
-2,698
-57% -$329K ﹤0.01% 931
2017
Q3 		$666K Sell
4,744
-128
-3% -$17.4K ﹤0.01% 698
2017
Q2 		$593K Buy
4,872
+171
+4% +$19.9K ﹤0.01% 757
2017
Q1 		$570K Sell
4,701
-193
-4% -$24.9K ﹤0.01% 778
2016
Q4 		$599K Sell
4,894
-188
-4% -$23K ﹤0.01% 762
2016
Q3 		$623K Sell
5,082
-422
-8% -$54.3K ﹤0.01% 755
2016
Q2 		$643K Buy
5,504
+168
+3% +$23.8K ﹤0.01% 701
2016
Q1 		$743K Buy
5,336
+193
+4% +$28.3K ﹤0.01% 657
2015
Q4 		$981K Sell
5,143
-360
-7% -$62.9K 0.01% 573
2015
Q3 		$861K Buy
5,503
+247
+5% +$45.1K 0.01% 631
2015
Q2 		$950K Sell
5,256
-33
-0.6% -$5.7K 0.01% 628
2015
Q1 		$917K Sell
5,289
-174
-3% -$31.5K 0.01% 666
2014
Q4 		$1.01M Sell
5,463
-362
-6% -$67.1K 0.01% 624
2014
Q3 		$966K Sell
5,825
-4,076
-41% -$669K 0.01% 639
2014
Q2 		$1.55M Sell
9,901
-326
-3% -$51.5K 0.01% 505
2014
Q1 		$1.56M Sell
10,227
-2,704
-21% -$430K 0.01% 494
2013
Q4 		$1.72M Buy
12,931
+194
+2% +$23.3K 0.01% 461
2013
Q3 		$1.48M Sell
12,737
-410,953
-97% -$45.1M 0.01% 495
2013
Q2 		$39.5M Buy
+423,690
New +$40.8M 0.15% 176

Other funds holding ALXN

BCI
Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return
NICM
Neo Ivy Capital Management New York $379M AUM 28.34% 1-Year Est. Return
TAIM
TD Ameritrade Investment Management Omaha, Nebraska $9.4B AUM 7.2% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
RG
Retirement Group San Diego, California $279M AUM 22.21% 1-Year Est. Return
CFO
CVA Family Office Denver, Colorado $950M AUM 20.72% 1-Year Est. Return
MAM
Meeder Asset Management Dublin, Ohio $1.75B AUM 34.85% 1-Year Est. Return

KeyBank National Association's ALXN Position: Q3 2021 in Review

KeyBank National Association sold out of Alexion Pharmaceuticals (ALXN) in Q3 2021, closing a stake of 1,252 shares — an estimated $230K sold.

KeyBank National Association first reported a position in ALXN in Q2 2013 and held it in 20 quarters. The position peaked at $39.5M in Q2 2013. 7 funds tracked by Wall St. Rank hold ALXN as of Q3 2021.

  • KeyBank National Association reported no remaining Alexion Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
  • KeyBank National Association sold 1,252 Alexion Pharmaceuticals shares in Q3 2021, an estimated $230K.
  • KeyBank National Association first reported a position in Alexion Pharmaceuticals in Q2 2013 and held it in 20 quarters.
  • KeyBank National Association's Alexion Pharmaceuticals position peaked at $39.5M in Q2 2013.
  • 7 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q3 2021.

Based on KeyBank National Association's 13F filing for Q3 2021, filed 8 Nov 2021.